News

Sanome is delighted that Co-Founder, Paul Aykroyd has accepted the role of COO. 

Catch up on Sanome’s Founder & CEO, Benedikt von Thüngen’s interview with PKV-Verband.

Meet some of Sanome’s brilliant Technical Advisory team. Comprised of experts in the field of machine learning, data science, bioinformatics and AI.

Dr Andrew Creagh joins the Sanome team as Lead AI/ML Scientist, from his post at Oxford University.

Founder & CEO Benedikt von Thüngen spoke at AWS event, showcasing Sanome’s technology and sharing insights into the power and potential of generative AI for healthcare.

The RHN is a leading provider of specialist healthcare and neuro-rehabilitation services, serving patients with severe and complex neuro-disability, and Sanome is committed to developing cutting-edge technology solutions to improve patient outcomes.

Sanome awarded i4i FAST Grant to develop Early Warning Systems for health deteriorations.

Meet some of Sanome’s brilliant Clinical Advisory team. Comprised of nurses, NHS Doctors and beyond.

Sanome has received funding to support the development and evidence generation of its biomarker-based early warning system for patients receiving long-term specialist inpatient care.

“AstraZeneca isn’t the only pharmaceutical business pursuing digital-twin research. […] U.K.-based startup Sanome is working toward a digital twin to detect health changes as early as possible.”